Patient Guide: Observational Study in Patients With Previously Unresectable Malignant Pleural Mesothelioma Treated With Nivolumab and Ipilimumab (MESO-IMMUNE)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 63 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT05308966
Status: ACTIVE_NOT_RECRUITING
Condition: Malignant Pleural Mesothelioma, Unresectable Malignant Neoplasm
Phase: Not Specified

Find a Study Location Near You

This study is available at 63 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Aix-en-Provence,
  • Albi,
  • Angers,
  • • And 60 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily